BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9882702)

  • 1. Constitutive activation of the human bradykinin B2 receptor induced by mutations in transmembrane helices III and VI.
    Marie J; Koch C; Pruneau D; Paquet JL; Groblewski T; Larguier R; Lombard C; Deslauriers B; Maigret B; Bonnafous JC
    Mol Pharmacol; 1999 Jan; 55(1):92-101. PubMed ID: 9882702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation.
    Quitterer U; AbdAlla S; Jarnagin K; Müller-Esterl W
    Biochemistry; 1996 Oct; 35(41):13368-77. PubMed ID: 8873604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of the conserved proline in helix 6 of the human bradykinin B2 receptor.
    Haffemayer B; Richard E; Mattras H; Marie J
    Biochem Biophys Res Commun; 2008 Feb; 366(4):1001-6. PubMed ID: 18096516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure.
    Marie J; Richard E; Pruneau D; Paquet JL; Siatka C; Larguier R; Poncé C; Vassault P; Groblewski T; Maigret B; Bonnafous JC
    J Biol Chem; 2001 Nov; 276(44):41100-11. PubMed ID: 11495910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111).
    Feng YH; Miura S; Husain A; Karnik SS
    Biochemistry; 1998 Nov; 37(45):15791-8. PubMed ID: 9843384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the B2 bradykinin receptor reveal a different pattern of contacts for peptidic agonists and peptidic antagonists.
    Jarnagin K; Bhakta S; Zuppan P; Yee C; Ho T; Phan T; Tahilramani R; Pease JH; Miller A; Freedman R
    J Biol Chem; 1996 Nov; 271(45):28277-86. PubMed ID: 8910447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intracellular tyrosine residue mutation and carboxyl terminus truncation on signal transduction and internalization of the rat bradykinin B2 receptor.
    Prado GN; Taylor L; Polgar P
    J Biol Chem; 1997 Jun; 272(23):14638-42. PubMed ID: 9169425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin.
    Schroeder C; Breit A; Böning H; Dedio J; Gera L; Stewart J; Müller-Esterl W
    Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H1924-32. PubMed ID: 12574004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist.
    Drube S; Liebmann C
    Br J Pharmacol; 2000 Dec; 131(8):1553-60. PubMed ID: 11139431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy.
    Pizard A; Blaukat A; Michineau S; Dikic I; Müller-Esterl W; Alhenc-Gelas F; Rajerison RM
    Biochemistry; 2001 Dec; 40(51):15743-51. PubMed ID: 11747451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of aspartate residues in the third extracellular loop of the rat B2 bradykinin receptor decreases affinity for bradykinin.
    Novotny EA; Bednar DL; Connolly MA; Connor JR; Stormann TM
    Biochem Biophys Res Commun; 1994 Jun; 201(2):523-30. PubMed ID: 8002982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
    Field JL; Butt SK; Morton IK; Hall JM
    Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
    Reyes-Cruz G; Vázquez-Prado J; Müller-Esterl W; Vaca L
    J Cell Biochem; 2000 Jan; 76(4):658-73. PubMed ID: 10653985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor.
    Kalatskaya I; Schüssler S; Blaukat A; Müller-Esterl W; Jochum M; Proud D; Faussner A
    J Biol Chem; 2004 Jul; 279(30):31268-76. PubMed ID: 15161928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insight into the role of the second intracellular loop of the bradykinin 2 receptor in signaling and internalization.
    Piserchio A; Prado GN; Zhang R; Yu J; Taylor L; Polgar P; Mierke DF
    Biopolymers; 2002 Apr; 63(4):239-46. PubMed ID: 11807751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains.
    Leeb-Lundberg LM; Kang DS; Lamb ME; Fathy DB
    J Biol Chem; 2001 Mar; 276(12):8785-92. PubMed ID: 11134011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual bradykinin B2 receptor signalling in A431 human epidermoid carcinoma cells: activation of protein kinase C is counteracted by a GS-mediated stimulation of the cyclic AMP pathway.
    Liebmann C; Graness A; Ludwig B; Adomeit A; Boehmer A; Boehmer FD; Nürnberg B; Wetzker R
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):109-18. PubMed ID: 8546671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.